The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 3.18

SEER Incidencea and U.S. Mortalityb Rates and Trends for the Top 5 Cancer Sitesc by Age

All Races, Males, 1975-2018

Ages 15-19

Site Incidence Mortality
1975-2018 2009-2018 1975-2018 2009-2018
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 21.9 0.7* 24.6 0.7* 4.6 -1.7* 3.3 -0.3
Hodgkin Lymphoma 3.3 -0.5* 3.2 -0.5* 0.2 -5.2* 0.0 -5.2*
Testis 3.1 0.1 3.4 -4.5 0.1 -4.9* 0.1 -2.4*
Brain and Other Nervous System 2.4 0.5 2.6 0.5 0.7 -0.9* 0.6 -0.9*
Non-Hodgkin Lymphoma 2.2 1.5* 2.8 1.5* 0.4 -3.3* 0.2 -3.3*
Bones and Joints 1.9 0.3 2.0 0.3 0.7 -1.1* 0.6 0.0

Ages 20-24

Site Incidence Mortality
1975-2018 2009-2018 1975-2018 2009-2018
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 34.1 0.6* 37.1 0.6* 6.3 -1.6* 4.8 -1.3*
Testis 9.1 0.9* 10.5 0.9* 0.5 -3.4* 0.3 -0.4
Hodgkin Lymphoma 4.9 -0.4* 4.5 -0.4* 0.4 -5.7* 0.1 -10.9*
Non-Hodgkin Lymphoma 2.7 1.3* 3.2 1.3* 0.6 -2.6* 0.3 -5.0*
Melanoma of the Skin 2.7 -0.6 2.4 -3.5* 0.2 -4.7* 0.1 -11.4*
Brain and Other Nervous System 2.6 0.1 2.5 0.1 0.7 -0.7* 0.6 -0.7*

Ages 25-29

Site Incidence Mortality
1975-2018 2009-2018 1975-2018 2009-2018
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 50.8 0.5 54.2 -1.2* 8.4 -1.7* 6.5 -2.4*
Testis 13.0 0.7* 14.9 -1.4 0.6 -2.8* 0.5 0.7
Melanoma of the Skin 5.1 -1.3 4.8 -6.5 0.5 -3.7* 0.3 -6.2*
Hodgkin Lymphoma 5.0 -0.3* 4.6 -0.3* 0.6 -4.7* 0.2 -4.7*
Non-Hodgkin Lymphoma 4.4 1.2 4.6 0.4 0.9 -2.1* 0.5 -5.1*
Kaposi sarcoma 3.4 - 1.4 - - - - -

Ages 30-34

Site Incidence Mortality
1975-2018 2009-2018 1975-2018 2009-2018
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 71.8 0.7 74.5 -0.4 12.9 -1.4* 9.9 -1.0*
Testis 13.5 1.7* 15.8 0.7* 0.6 -2.2* 0.4 1.8*
Melanoma of the Skin 8.4 0.1 8.5 0.1 1.0 -2.5* 0.5 -2.8*
Kaposi sarcoma 7.4 - 1.9 - - - - -
Non-Hodgkin Lymphoma 7.0 1.8* 5.9 -0.7 1.3 -1.5* 0.7 -3.1*
Hodgkin Lymphoma 4.2 -0.1 4.0 -0.1 0.7 -4.5* 0.2 -5.3*

Ages 35-39

Site Incidence Mortality
1975-2018 2009-2018 1975-2018 2009-2018
Rate AAPCd Rate AAPCd Rate AAPCd Rate AAPCd
All Malignant Cancers 100.6 0.5* 97.7 0.2 22.5 -1.5* 16.8 -0.6*
Melanoma of the Skin 12.1 0.5 11.8 -0.5* 1.5 -2.5* 0.9 -2.2*
Testis 11.3 1.7* 12.6 0.5* 0.5 -2.5* 0.4 -1.0*
Non-Hodgkin Lymphoma 10.4 1.6 8.5 -3.8* 1.9 -1.8* 0.9 -2.7*
Kaposi sarcoma 8.8 - 1.8 - - - - -
Colon and Rectum 8.1 1.1* 10.5 2.2* 2.3 -0.1 2.6 2.2*

Footnotes:

Rates are per 100,000.

a SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b US Mortality Files, National Center for Health Statistics, CDC.

c Top 5 cancer sites selected based on 1975-2018 rates for the age group.

d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2018.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.